AGOMAB ANNOUNCES FIRST PATIENT DOSED IN GLOBAL NOV-ERA PHASE 2B STUDY OF ONTUNISERTIB IN FIBROSTENOSING CROHN'S DISEASE

Reuters · 2d ago

Please log in to view news